About this trial
This clinical trial aims to evaluate the use of a contactless and non-invasive technique to measure the properties of the skin's microcirculation and its regulatory functions in both healthy individuals and patients with microvascular disease associated with type 1 diabetes. It is hoped that the study results will lead to the development of a useful method for detecting diabetic complications at an early stage, thereby enabling treatment and preventive measures before the onset of severe microangiopathy.
Eligibility criteria
Qualifiers
Diabetes mellitus type 1.
Cohort specific inclusion criteria apply, please review 'groups' section.
Disqualifiers
Patients unable to understand patient information due to cognitive impairment.
Patients unable to understand patient information due to language barriers.
Ongoing acute infection disease or inflammatory condition.
Pregnant or breast-feeding women.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Karolinska Institutet
Lead sponsor
Neko Health AB
Collaborator